Europe Tissue Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Disease Type (Breast Cancer, Lymphoma, Prostate Cancer, Gastric Cancer, Non-small Cell Lung Cancer, and Others), By End User, By Country and Growth Forecas

Europe Tissue Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Disease Type (Breast Cancer, Lymphoma, Prostate Cancer, Gastric Cancer, Non-small Cell Lung Cancer, and Others), By End User, By Country and Growth Forecast, 2023 - 2030


The Europe Tissue Diagnostics Market would witness market growth of 8.7% CAGR during the forecast period (2023-2030).

The adoption of tissue diagnostics is not limited to traditional pathology laboratories. It spans various healthcare settings, including hospitals, academic research institutions, reference laboratories, and diagnostic centers. The demand for accurate and reliable diagnostic information has led to integrating tissue diagnostics into various medical specialties, such as oncology, infectious diseases, autoimmune disorders, and neurological conditions.

Furthermore, the applications of tissue diagnostics are broad and encompass various medical fields. Oncology is one of the primary areas where it has been substantially impacted. Tumor characterization, grading, and determination of biomarker expression play a crucial role in cancer diagnosis and treatment planning. It helps identify specific genetic mutations, expression patterns, and tumor heterogeneity, facilitating the selection of targeted therapies and personalized treatment regimens.

Prostate cancer incidence rates in Europe are substantial, with the disease representing a major public health concern. The aging population, lifestyle factors, and genetic predisposition contribute to the high prevalence of prostate cancer. The escalating incidence of diagnosed cases necessitates more effective and dependable tissue diagnostics to enable timely identification and well-informed therapeutic choices. As per the data from the European Commission, it is estimated that, in EU-27 countries in 2020, prostate cancer accounted for 23.2% of all new cancer cases (excluding non-melanoma skin cancers) diagnosed in men and 9.9% of all deaths due to cancer in men. This made it the most frequently occurring cancer in men and the third cause of cancer death in men–after lung and colorectal cancers. Thus, rising breast and prostate cancer cases in Europe will help in the growth of the regional market.

The Germany market dominated the Europe Tissue Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $631.8 million by 2030. The UK market is exhibiting a CAGR of 7.7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.5% during (2023 - 2030).

Based on Product, the market is segmented into Consumables (Antibodies, Kits, Reagents, Probes), and Instruments (Slide-staining Systems, Scanners, Tissue Processing Systems, Others). Based on Technology, the market is segmented into Immunohistochemistry, In Situ Hybridization, Digital Pathology & Workflow, and Special Staining. Based on Disease Type, the market is segmented into Breast Cancer, Lymphoma, Prostate Cancer, Gastric Cancer, Non-small Cell Lung Cancer, and Others. Based on End User, the market is segmented into Hospitals, Research Laboratories, Pharmaceutical Organizations, Contract Research Organizations (CROs), and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • PHC Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Merck KGaA
  • Sakura Finetek USA, Inc.
  • Abcam Plc
  • Amos scientific Pty Ltd.
  • Dakewe Biotech Co., Ltd.
Europe Tissue Diagnostics Market Report Segmentation

By Product
  • Consumables
  • Instruments
By Technology
  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology & Workflow
  • Special Staining
By Disease Type
  • Breast Cancer
  • Lymphoma
  • Prostate Cancer
  • Gastric Cancer
  • Non-small Cell Lung Cancer
  • Others
By End User
  • Hospitals
  • Research Laboratories
  • Pharmaceutical Organizations
  • Contract Research Organizations (CROs)
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tissue Diagnostics Market, by Product
1.4.2 Europe Tissue Diagnostics Market, by Technology
1.4.3 Europe Tissue Diagnostics Market, by Disease Type
1.4.4 Europe Tissue Diagnostics Market, by End User
1.4.5 Europe Tissue Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Porter Five Forces Analysis
Chapter 5. Europe Tissue Diagnostics Market by Product
5.1 Europe Consumables Market by Country
5.2 Europe Tissue Diagnostics Market by Consumables Product
5.2.1 Europe Antibodies Market by Country
5.2.2 Europe Kits Market by Country
5.2.3 Europe Reagents Market by Country
5.2.4 Europe Probes Market by Country
5.3 Europe Instruments Market by Country
5.4 Europe Tissue Diagnostics Market by Instruments Product
5.4.1 Europe Slide-staining Systems Market by Country
5.4.2 Europe Scanners Market by Country
5.4.3 Europe Tissue Processing Systems Market by Country
5.4.4 Europe Others Market by Country
Chapter 6. Europe Tissue Diagnostics Market by Technology
6.1 Europe Immunohistochemistry Market by Country
6.2 Europe In Situ Hybridization Market by Country
6.3 Europe Digital Pathology & Workflow Market by Country
6.4 Europe Special Staining Market by Country
Chapter 7. Europe Tissue Diagnostics Market by Disease Type
7.1 Europe Breast Cancer Market by Country
7.2 Europe Lymphoma Market by Country
7.3 Europe Prostate Cancer Market by Country
7.4 Europe Gastric Cancer Market by Country
7.5 Europe Non-small Cell Lung Cancer Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Tissue Diagnostics Market by End User
8.1 Europe Hospitals Market by Country
8.2 Europe Research Laboratories Market by Country
8.3 Europe Pharmaceutical Organizations Market by Country
8.4 Europe Contract Research Organizations (CROs) Market by Country
8.5 Europe Others Market by Country
Chapter 9. Europe Tissue Diagnostics Market by Country
9.1 Germany Tissue Diagnostics Market
9.1.1 Germany Tissue Diagnostics Market by Product
9.1.1.1 Germany Tissue Diagnostics Market by Consumables Product
9.1.1.2 Germany Tissue Diagnostics Market by Instruments Product
9.1.2 Germany Tissue Diagnostics Market by Technology
9.1.3 Germany Tissue Diagnostics Market by Disease Type
9.1.4 Germany Tissue Diagnostics Market by End User
9.2 UK Tissue Diagnostics Market
9.2.1 UK Tissue Diagnostics Market by Product
9.2.1.1 UK Tissue Diagnostics Market by Consumables Product
9.2.1.2 UK Tissue Diagnostics Market by Instruments Product
9.2.2 UK Tissue Diagnostics Market by Technology
9.2.3 UK Tissue Diagnostics Market by Disease Type
9.2.4 UK Tissue Diagnostics Market by End User
9.3 France Tissue Diagnostics Market
9.3.1 France Tissue Diagnostics Market by Product
9.3.1.1 France Tissue Diagnostics Market by Consumables Product
9.3.1.2 France Tissue Diagnostics Market by Instruments Product
9.3.2 France Tissue Diagnostics Market by Technology
9.3.3 France Tissue Diagnostics Market by Disease Type
9.3.4 France Tissue Diagnostics Market by End User
9.4 Russia Tissue Diagnostics Market
9.4.1 Russia Tissue Diagnostics Market by Product
9.4.1.1 Russia Tissue Diagnostics Market by Consumables Product
9.4.1.2 Russia Tissue Diagnostics Market by Instruments Product
9.4.2 Russia Tissue Diagnostics Market by Technology
9.4.3 Russia Tissue Diagnostics Market by Disease Type
9.4.4 Russia Tissue Diagnostics Market by End User
9.5 Spain Tissue Diagnostics Market
9.5.1 Spain Tissue Diagnostics Market by Product
9.5.1.1 Spain Tissue Diagnostics Market by Consumables Product
9.5.1.2 Spain Tissue Diagnostics Market by Instruments Product
9.5.2 Spain Tissue Diagnostics Market by Technology
9.5.3 Spain Tissue Diagnostics Market by Disease Type
9.5.4 Spain Tissue Diagnostics Market by End User
9.6 Italy Tissue Diagnostics Market
9.6.1 Italy Tissue Diagnostics Market by Product
9.6.1.1 Italy Tissue Diagnostics Market by Consumables Product
9.6.1.2 Italy Tissue Diagnostics Market by Instruments Product
9.6.2 Italy Tissue Diagnostics Market by Technology
9.6.3 Italy Tissue Diagnostics Market by Disease Type
9.6.4 Italy Tissue Diagnostics Market by End User
9.7 Rest of Europe Tissue Diagnostics Market
9.7.1 Rest of Europe Tissue Diagnostics Market by Product
9.7.1.1 Rest of Europe Tissue Diagnostics Market by Consumables Product
9.7.1.2 Rest of Europe Tissue Diagnostics Market by Instruments Product
9.7.2 Rest of Europe Tissue Diagnostics Market by Technology
9.7.3 Rest of Europe Tissue Diagnostics Market by Disease Type
9.7.4 Rest of Europe Tissue Diagnostics Market by End User
Chapter 10. Company Profiles
10.1 F. Hoffmann-La Roche Ltd.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 SWOT Analysis
10.3 PHC Holdings Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Partnerships, Collaborations, and Agreements:
10.3.5 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Abbott Laboratories
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Merck KGaA
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.6.6 SWOT Analysis
10.7 Sakura Finetek USA, Inc.
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Abcam Plc
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 SWOT Analysis
10.9 Amos scientific Pty Ltd.
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Dakewe Biotech Co., Ltd.
10.10.1 Company Overview
10.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings